Dorsavi Ltd
DVL.ASXHealth Care
Medical research and development, supplying medical, sporting and occupational health and safety products, devices and services.
Market Data
$0.046
+0.1%$49.6M
-100000.0x
$-0.005
0.00%
+0.1%
Latest Earnings
Appendix 4D and Half Year Financial Report
26 February 2026
DorsaVi Limited reported a significant deterioration in half-year results with revenue declining 8.3% to $764k and losses surging 520% to $3.6M, primarily driven by a $2.9M increase in share-based payment expenses. The company raised $4.9M in capital during the period, improving cash position to $5.0M, but faces ongoing profitability challenges and material uncertainty about its ability to continue as a going concern. Key points: Successfully raised $4.9M in capital during the period through multiple share placements; Cash position improved significantly to $5.0M from $2.3M at June 2025; Net tangible assets per share increased to 0.49 cents from 0.23 cents
Recent Announcements
Ceasing to be a substantial holder
Annexure 'A' ceased to be a substantial holder.
Appendix 4D and Half Year Financial Report
DorsaVi Limited reported a significant deterioration in half-year results with revenue declining 8.3% to $764k and losses surging 520% to $3.6M, primarily driven by a $2.9M increase in share-based payment expenses. The company raised $4.9M in capital during the period, improving cash position to $5.0M, but faces ongoing profitability challenges and material uncertainty about its ability to continue as a going concern. Key points: Successfully raised $4.9M in capital during the period through multiple share placements; Cash position improved significantly to $5.0M from $2.3M at June 2025; Net tangible assets per share increased to 0.49 cents from 0.23 cents
Get real-time alerts for DVL
Receive AI-powered earnings summaries and instant notifications when Dorsavi Ltd releases results.
Register Free